Ricard Masia

3.6k total citations · 1 hit paper
72 papers, 2.2k citations indexed

About

Ricard Masia is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Ricard Masia has authored 72 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 15 papers in Hepatology and 14 papers in Molecular Biology. Recurrent topics in Ricard Masia's work include Liver Disease Diagnosis and Treatment (17 papers), Cardiac Ischemia and Reperfusion (9 papers) and Liver Disease and Transplantation (8 papers). Ricard Masia is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Cardiac Ischemia and Reperfusion (9 papers) and Liver Disease and Transplantation (8 papers). Ricard Masia collaborates with scholars based in United States, Canada and Australia. Ricard Masia's co-authors include Kathleen E. Corey, Colin G. Nichols, Raymond T. Chung, Gregory Y. Lauwers, Stephanie A. Osganian, Tracey G. Simon, Jacqueline B. Henson, Maryam Kherad Pezhouh, Jonathan Chen and Klaus W. Beyenbach and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Ricard Masia

70 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis

2016 313 citations Xiaobo Wang, Ze Zheng et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ricard Masia United States	27	817	603	432	372	370	72	2.2k
Shinya Sato Japan	23	410 0.5×	536 0.9×	305 0.7×	495 1.3×	238 0.6×	102	1.9k
Shinji Iwasaki Japan	22	764 0.9×	530 0.9×	371 0.9×	79 0.2×	257 0.7×	80	1.9k
Hongyun She United States	18	654 0.8×	617 1.0×	439 1.0×	137 0.4×	219 0.6×	19	1.6k
Sanae Haga Japan	21	497 0.6×	646 1.1×	432 1.0×	127 0.3×	371 1.0×	43	1.7k
Fawzia Bardag‐Gorce United States	31	734 0.9×	1.5k 2.4×	213 0.5×	589 1.6×	212 0.6×	93	2.6k
Hélène Gilgenkrantz France	33	1.1k 1.3×	1.7k 2.8×	1.2k 2.9×	208 0.6×	883 2.4×	97	3.7k
Isao Okazaki Japan	25	939 1.1×	693 1.1×	1.2k 2.9×	175 0.5×	485 1.3×	102	2.5k
Haoming Zhou China	28	643 0.8×	1.2k 2.0×	347 0.8×	100 0.3×	382 1.0×	72	2.6k
Pamela L. Tuma United States	24	403 0.5×	1.1k 1.8×	128 0.3×	205 0.6×	607 1.6×	55	2.4k
Anna Moles Spain	20	477 0.6×	486 0.8×	338 0.8×	127 0.3×	166 0.4×	29	1.3k

Countries citing papers authored by Ricard Masia

Since Specialization

Citations

This map shows the geographic impact of Ricard Masia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricard Masia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricard Masia more than expected).

Fields of papers citing papers by Ricard Masia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricard Masia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricard Masia. The network helps show where Ricard Masia may publish in the future.

Co-authorship network of co-authors of Ricard Masia

This figure shows the co-authorship network connecting the top 25 collaborators of Ricard Masia. A scholar is included among the top collaborators of Ricard Masia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricard Masia. Ricard Masia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Panduro, Marisella, Ricard Masia, Andrew C. Lake, et al.. (2023). Abstract 5125: Depletion of CCR8+ tumor Treg cells with SRF114 or anti-CCR8 therapy promotes robust antitumor activity and reshapes the tumor microenvironment toward a more pro-inflammatory milieu. Cancer Research. 83(7_Supplement). 5125–5125. 1 indexed citations

Jacoberger-Foissac, Célia, Isabelle Cousineau, Yacine Barèche, et al.. (2022). CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic Cancer. Cancer Immunology Research. 11(1). 56–71. 46 indexed citations

Shih, Angela, Bita V. Naini, Maria Westerhoff, et al.. (2022). Cytomegalovirus Hepatitis in Allograft Livers May Show Histologic Features of Acute Cellular Rejection. Archives of Pathology & Laboratory Medicine. 147(6). 655–664. 1 indexed citations

Corey, Kathleen E., Rebecca Pitts, Michelle Lai, et al.. (2021). ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD. Journal of Hepatology. 76(1). 25–33. 48 indexed citations

Kinsella, Paul, Olivia Smibert, John Whitlam, et al.. (2021). Successful use of azithromycin for Escherichia coli–associated renal allograft malakoplakia: a report of two cases. European Journal of Clinical Microbiology & Infectious Diseases. 40(12). 2627–2631. 5 indexed citations

Luther, Jay, Sanjoy K. Khan, Manish Gala, et al.. (2020). Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation. Proceedings of the National Academy of Sciences. 117(21). 11667–11673. 69 indexed citations

Goodman, Russell P., Andrew L. Markhard, Hardik Shah, et al.. (2020). Hepatic NADH reductive stress underlies common variation in metabolic traits. Nature. 583(7814). 122–126. 142 indexed citations

Brackett, Diane, Azfar Neyaz, Kshitij S. Arora, et al.. (2019). Cholangiolar pattern and albumin in situ hybridisation enable a diagnosis of intrahepatic cholangiocarcinoma. Journal of Clinical Pathology. 73(1). 23–29. 15 indexed citations

Papadodima, Stavroula, Ricard Masia, & James R. Stone. (2019). Cardiac iron overload following liver transplantation in patients without hereditary hemochromatosis or severe hepatic iron deposition. Cardiovascular Pathology. 40. 7–11. 3 indexed citations

10.

Holmes, Jacinta A., Eoin R. Feeney, Annie J. Kruger, et al.. (2018). Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection. The Journal of Infectious Diseases. 218(9). 1394–1403. 36 indexed citations

11.

Kruger, Annie J., Bryan C. Fuchs, Ricard Masia, et al.. (2018). Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet‐induced mouse model of nonalcoholic steatohepatitis. Hepatology Communications. 2(5). 529–545. 50 indexed citations

12.

Chen, Jonathan, Maryam Kherad Pezhouh, Gregory Y. Lauwers, & Ricard Masia. (2017). Histopathologic Features of Colitis Due to Immunotherapy With Anti-PD-1 Antibodies. The American Journal of Surgical Pathology. 41(5). 643–654. 134 indexed citations

13.

Wang, Xiaobo, Ze Zheng, Jorge Matías Caviglia, et al.. (2016). Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis. Cell Metabolism. 24(6). 848–862. 313 indexed citations breakdown →

14.

Valsangkar, Nakul P., Thun Ingkakul, Camilo Correa‐Gallego, et al.. (2015). Survival in ampullary cancer: Potential role of different KRAS mutations. Surgery. 157(2). 260–268. 32 indexed citations

15.

Sherry, Nicole, et al.. (2013). Case 16-2013. New England Journal of Medicine. 368(21). 2015–2024. 4 indexed citations

16.

Masia, Ricard & Gary Yellen. (2012). Outwardly Rectifying Currents in Hepatocytes are Inhibited by 2-APB. Biophysical Journal. 102(3). 680a–680a. 1 indexed citations

17.

Masia, Ricard & Colin G. Nichols. (2008). Functional Clustering of Mutations in the Dimer Interface of the Nucleotide Binding Folds of the Sulfonylurea Receptor. Journal of Biological Chemistry. 283(44). 30322–30329. 26 indexed citations

18.

Flagg, Thomas P., et al.. (2007). Arrhythmia susceptibility and premature death in transgenic mice overexpressing both SUR1 and Kir6.2[ΔN30,K185Q] in the heart. American Journal of Physiology-Heart and Circulatory Physiology. 293(1). H836–H845. 24 indexed citations

19.

Masia, Ricard, Decha Enkvetchakul, & Charles W. Nichols. (2005). Differential nucleotide regulation of K channels by SUR1 and SUR2A. Journal of Molecular and Cellular Cardiology. 39(3). 491–501. 66 indexed citations

20.

Flagg, Thomas P., et al.. (2005). Transgenic overexpression of SUR1 in the heart suppresses sarcolemmal K. Journal of Molecular and Cellular Cardiology. 39(4). 647–656. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact